Skip to content

Drug interactions

Bosentan + Venetoclax

Severity: Major

Bosentan and Venetoclax: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Bosentan may reduce venetoclax exposure, potentially decreasing efficacy in leukemia or lymphoma. Moderate CYP3A inducers are advised against in labeling.

What this interaction means in plain words

Bosentan and Venetoclax can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Bosentan belongs to Miscellaneous; Venetoclax belongs to Miscellaneous.

Evidence level: Moderate

Why it happens

Bosentan induces CYP3A4, increasing venetoclax metabolism.

What to do

Avoid the combination and consider alternatives with less CYP3A induction. If unavoidable, monitor disease response closely.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Bosentan and Venetoclax, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Bosentan with Venetoclax?

MediHelp rates the interaction as major. Bosentan and Venetoclax can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Bosentan may reduce venetoclax exposure, potentially decreasing efficacy in leukemia or lymphoma. Moderate CYP3A inducers are advised against in labeling.

How serious is the interaction between Bosentan and Venetoclax?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid the combination and consider alternatives with less CYP3A induction. If unavoidable, monitor disease response closely.

What other medicines interact with Bosentan?

MediHelp also lists interactions of Bosentan with, for example, Cyclosporin, Cyclosporine, Glyburide. The full list is on the Bosentan page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in